ASHA MATHEWS: Open Payments
NPI 1669759841 · LYNBROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 86 payments from 22 companies in 2025. Trend: 2023 $954 · 2024 $1,700 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $423 |
| Alexion Pharmaceuticals, Inc. | 9 | $177 |
| ARGENX US, INC. | 5 | $107 |
| Neurocrine BioSciences, Inc. | 3 | $102 |
| Grifols USA, LLC | 4 | $100 |
| Lundbeck LLC | 4 | $98 |
| Otsuka America Pharmaceutical, Inc. | 5 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Amgen Inc. | 3 | $63 |
| Axsome Therapeutics, Inc. | 2 | $57 |
Products named: ULTOMIRIS, QULIPTA, UBRELVY, VYVGART, INGREZZA, Gamunex-C, VYEPTI, REXULTI.
Industry payments across NY — which companies pay providers there.
